These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 6546792

  • 1. Vitamin D metabolism in osteogenesis imperfecta during calcitonin therapy.
    Nishi Y, Hyodo S, Yoshimitsu K, Sawano K, Yamaoka K, Seino Y, Usui T.
    Pediatrics; 1984 Apr; 73(4):538-42. PubMed ID: 6546792
    [Abstract] [Full Text] [Related]

  • 2. Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate.
    Devlin RD, Gutteridge DH, Prince RL, Retallack RW, Worth GK.
    J Bone Miner Res; 1990 Nov; 5(11):1121-6. PubMed ID: 2125401
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of synthetic salmon calcitonin in osteogenesis imperfecta.
    Castells S, Lu C, Baker RK, Wallach S.
    Curr Ther Res Clin Exp; 1974 Jan; 16(1):1-14. PubMed ID: 4203843
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vitamin D metabolites in diabetic patients: decreased serum concentration of 24,25-dihydroxyvitamin D.
    Christiansen C, Christensen MS, McNair P, Nielsen B, Madsbad S.
    Scand J Clin Lab Invest; 1982 Oct; 42(6):487-91. PubMed ID: 6760373
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Alkaline phosphatase and its isoenzyme activity of the blood in osteogenesis imperfecta before and during treatment with calcitonin].
    Bodziony J, Lukas W, Stanosek J, Ziarek S.
    Padiatr Grenzgeb; 1988 Oct; 27(4):259-67. PubMed ID: 3174140
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of osteogenesis imperfecta with calcitonin].
    Iester A, Marchesi A, Fásce L.
    Minerva Pediatr; 1979 Mar 31; 31(6):443-500. PubMed ID: 470887
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Influence of ultraviolet irradiation on plasma vitamin D and calcitonin levels in humans.
    Kokot F, Schmidt-Gayk H, Wiecek A, Mleczko Z, Bracel B.
    Kidney Int Suppl; 1989 Nov 31; 27():S143-6. PubMed ID: 2636650
    [Abstract] [Full Text] [Related]

  • 16. [Calcitonin and phosphate metabolism. Analysis of active calcium and phosphorus in children treated with Calcitar].
    Vulović D, Stojanov Lj, Nedeljković V, Banicević M, Zamurović D.
    Srp Arh Celok Lek; 1977 Nov 31; 105(11):967-74. PubMed ID: 617001
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Peri-osteocytic calcium fixation under calcitonin treatment. Microradiographic study using automatic analysis of images in 8 cases of osteogenesis imperfecta].
    Duriez J, Flautre B.
    Nouv Presse Med; 1975 Jan 11; 04(2):97-100. PubMed ID: 1138231
    [Abstract] [Full Text] [Related]

  • 19. Decreased serum 24,25-dihydroxyvitamin D concentration during long-term anticonvulsant therapy in adult epileptics.
    Zerwekh JE, Homan R, Tindall R, Pak CY.
    Ann Neurol; 1982 Aug 11; 12(2):184-6. PubMed ID: 6982022
    [Abstract] [Full Text] [Related]

  • 20. The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta type V.
    Zeitlin L, Rauch F, Travers R, Munns C, Glorieux FH.
    Bone; 2006 Jan 11; 38(1):13-20. PubMed ID: 16162424
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.